Please ensure Javascript is enabled for purposes of website accessibility The Wall Street Journal: Why Biotech’s Rally Can Last This Time - Janus Henderson Investors - Global Corporate
Find your local site

The Wall Street Journal: Why Biotech’s Rally Can Last This Time

Why is biotech rallying? Portfolio Manager Daniel Lyons explains why and analyzes the approval pipeline in the Wall Street Journal.

Dan Lyons Wall Street Journal (WSJ) Coverage
Feb 9, 2026
1 minute read

IMPORTANT INFORMATION

Links to other web sites are operated by third parties. Janus Henderson Investors is not affiliated with those web sites in any way and does not endorse, control, or maintain responsibility for the content of those linked web sites. All information, representations or offers made in linked third party web sites are solely the responsibility of the third parties operating those web sites and Janus Henderson Investors makes no representation or warranty as to accuracy or reliability of the information contained on linked third party web sites.

Go to Source